The HSF1/miR-135b-5p axis induces protective autophagy to promote oxaliplatin resistance through the MUL1/ULK1 pathway in colorectal cancer

[1]  Rui Zhang,et al.  LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes , 2020, Molecular Cancer.

[2]  Hao Liu,et al.  Regulation of Integrin Subunit Alpha 2 by miR-135b-5p Modulates Chemoresistance in Gastric Cancer , 2020, Frontiers in Oncology.

[3]  Xi Chen,et al.  The c-Myc/miR-27b-3p/ATG10 regulatory axis regulates chemoresistance in colorectal cancer , 2020, Theranostics.

[4]  Soo‐Young Choi,et al.  MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies , 2019, Cells.

[5]  Y. Ba,et al.  miR-135b Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Ahmedin Jemal,et al.  Cancer treatment and survivorship statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[7]  Z. Sheng,et al.  Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts , 2019, Nature Communications.

[8]  Wen-juan Wang,et al.  miR‐135b promotes proliferation and metastasis by targeting APC in triple‐negative breast cancer , 2019, Journal of cellular physiology.

[9]  Ji-cheng Tantai,et al.  Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7 , 2019, Cell Death & Disease.

[10]  Daling Zhu,et al.  Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression , 2019, OncoTargets and therapy.

[11]  L. Du,et al.  Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer , 2019, Molecular Cancer.

[12]  Fan Zhang,et al.  miR-135b-5p enhances doxorubicin-sensitivity of breast cancer cells through targeting anterior gradient 2 , 2019, Journal of Experimental & Clinical Cancer Research.

[13]  W. El-Rifai,et al.  Helicobacter pylori‐induced miR‐135b‐5p promotes cisplatin resistance in gastric cancer , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  G. Calin,et al.  MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. , 2019, Molecular aspects of medicine.

[15]  A. Khayat,et al.  APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes , 2018, BMC Cancer.

[16]  R. Amaravadi,et al.  Targeting autophagy in cancer , 2018, Cancer.

[17]  I. Dikic,et al.  Mechanism and medical implications of mammalian autophagy , 2018, Nature reviews. Molecular cell biology.

[18]  M. Ychou,et al.  Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  A. Lyakhovich,et al.  The interplay between autophagy and tumorigenesis: exploiting autophagy as a means of anticancer therapy , 2018, Biological reviews of the Cambridge Philosophical Society.

[20]  S. Tooze,et al.  Autophagy pathway: Cellular and molecular mechanisms , 2018, Autophagy.

[21]  I. Ganley,et al.  The mammalian ULK1 complex and autophagy initiation , 2017, Essays in biochemistry.

[22]  X. Che,et al.  miR-135b-5p Promotes migration, invasion and EMT of pancreatic cancer cells by targeting NR3C2. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  Yanfeng Liu,et al.  Upregulation of microRNA‐135b and microRNA‐182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway , 2017, Molecular carcinogenesis.

[24]  A. Thorburn,et al.  Targeting autophagy in cancer , 2017, Nature Reviews Cancer.

[25]  Fangfang Guo,et al.  Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy , 2017, Cell.

[26]  F. Slack,et al.  MicroRNA therapeutics: towards a new era for the management of cancer and other diseases , 2017, Nature Reviews Drug Discovery.

[27]  Jinmei Li,et al.  miR-135b reverses chemoresistance of non-small cell lung cancer cells by downregulation of FZD1. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  V. Rani,et al.  Exploring miRNA based approaches in cancer diagnostics and therapeutics. , 2016, Critical reviews in oncology/hematology.

[29]  Rong-jiang Wang,et al.  miR-135b inhibits tumour metastasis in prostate cancer by targeting STAT6 , 2015, Oncology letters.

[30]  Isabella Castiglioni,et al.  MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer , 2015, Theranostics.

[31]  Quan Chen,et al.  Mitochondrial outer-membrane E3 ligase MUL1 ubiquitinates ULK1 and regulates selenite-induced mitophagy , 2015, Autophagy.

[32]  K. Ohyashiki,et al.  Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. , 2014, Blood.

[33]  Joon-Oh Park,et al.  Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial. , 2014, The Lancet. Oncology.

[34]  L. Sistonen,et al.  HSF1 at a glance , 2014, Journal of Cell Science.

[35]  Masaaki Komatsu,et al.  Autophagy: Renovation of Cells and Tissues , 2011, Cell.

[36]  Sandra Barth,et al.  Autophagy: cellular and molecular mechanisms , 2010, The Journal of pathology.

[37]  Daniel J Klionsky,et al.  Mammalian autophagy: core molecular machinery and signaling regulation. , 2010, Current opinion in cell biology.

[38]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[39]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  Anindya Dutta,et al.  MicroRNAs in cancer. , 2009, Annual review of pathology.

[41]  N. Kemeny,et al.  Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Z. Zhai,et al.  GIDE is a mitochondrial E3 ubiquitin ligase that induces apoptosis and slows growth , 2008, Cell Research.

[43]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[44]  Akio Matsuda,et al.  Genome-Wide and Functional Annotation of Human E3 Ubiquitin Ligases Identifies MULAN, a Mitochondrial E3 that Regulates the Organelle's Dynamics and Signaling , 2008, PloS one.

[45]  Miguel A. Andrade-Navarro,et al.  Cargo-Selected Transport from the Mitochondria to Peroxisomes Is Mediated by Vesicular Carriers , 2008, Current Biology.

[46]  Daniel J Sargent,et al.  A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[47]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[48]  A F Slater,et al.  Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. , 1993, Pharmacology & therapeutics.